metronidazole and clobetasol

metronidazole has been researched along with clobetasol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Phillips, SB; Potts, CE; Shelanski, MV	1
Aung, PP; Curry, JL; Farah, M; Nagarajan, P; Nelson, KC; Prieto, VG; Tetzlaff, MT; Torres-Cabala, CA	1

Trials

1 trial(s) available for metronidazole and clobetasol

Article	Year
Evaluation of cutaneous reactivity to recently marketed dermatologic products. International journal of dermatology, 1996, Volume: 35, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Allergens; Antifungal Agents; Calcitriol; Clobetasol; Dermatitis, Irritant; Dermatologic Agents; Double-Blind Method; Doxepin; Drug Prescriptions; Female; Humans; Hypersensitivity; Imidazoles; Irritants; Ketoconazole; Male; Metronidazole; Middle Aged; Mupirocin; Naphthalenes; Patch Tests; Pharmaceutical Vehicles; Placebos; Risk Factors; Skin; Terbinafine	1996

Article

Year

Evaluation of cutaneous reactivity to recently marketed dermatologic products.

International journal of dermatology, 1996, Volume: 35, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Allergens; Antifungal Agents; Calcitriol; Clobetasol; Dermatitis, Irritant; Dermatologic Agents; Double-Blind Method; Doxepin; Drug Prescriptions; Female; Humans; Hypersensitivity; Imidazoles; Irritants; Ketoconazole; Male; Metronidazole; Middle Aged; Mupirocin; Naphthalenes; Patch Tests; Pharmaceutical Vehicles; Placebos; Risk Factors; Skin; Terbinafine

1996

Other Studies

2 other study(ies) available for metronidazole and clobetasol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report. Journal of cutaneous pathology, 2020, Volume: 47, Issue:5 Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chondrosarcoma; Clobetasol; Drug Therapy, Combination; Humans; Hyperpigmentation; Lichen Planus; Male; Metronidazole; Transforming Growth Factor beta; Treatment Outcome	2020

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report.

Journal of cutaneous pathology, 2020, Volume: 47, Issue:5

Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chondrosarcoma; Clobetasol; Drug Therapy, Combination; Humans; Hyperpigmentation; Lichen Planus; Male; Metronidazole; Transforming Growth Factor beta; Treatment Outcome

2020